Abalos Therapeutics is an Essen, Germany-based developer of novel immuno-virotherapies against cancer.

Biotechnology

Abalos Therapeutics

Abalos Therapeutics' headquarters in Essen, Germany

The Düsseldorf office serves as a strategic hub for governance and oversight, supporting the Board of Directors.

Düsseldorf

Marcus Kostka

Joerg Vollmer, PhD

Thomas Bogenrieder

Dethardt Müller

Jörg Vollmer

Philipp Lang

Karl Lang

Klaus Binder

Annegret De Baey-Diepolder

Sebastian Kreuz

The Scientific Research Team at Abalos Therapeutics is responsible for developing and optimizing novel immuno-virotherapies for cancer treatment. This team conducts in vivo immune-oncology studies, engages in bioprocess development, and collaborates across various scientific disciplines to advance therapeutic candidates from discovery through preclinical development.

Scientific Research Team

The Leadership Team at Abalos Therapeutics is responsible for setting the strategic direction, overseeing scientific and technological advancements, ensuring clinical development and regulatory compliance, and fostering innovation in the development of novel immuno-virotherapies against cancer. The team comprises key executive and scientific leaders who collaborate to drive the company's mission and objectives.

Abalos Therapeutics

Org chart

Board & advisors

Teams

Scientific Research Team

Leadership Team

Offices

Abalos Therapeutics

Org chart

Board & advisors

Teams

Scientific Research Team

Leadership Team

Offices

Related companies